Canadian Alopecia Areata Foundation
Predictable for an unpredictable disease.
On June 13th, a JAK inhibitor called Olumiant became the first FDA-approved treatment for alopecia areata. Read more and find out what this means for Canadians.
CoNCERT Pharmaceuticals' latest press release shows exciting potential for CTP-543 to be a best-in-class treatment for alopecia areata.
Dermatologist Dr. Jeffrey Donovan provides an overview of the treatments available for alopecia areata in a recent blog post. Link to article is within.